胆固醇药物诱导的肝损伤从Rad-140成功地用皮质类固醇治疗
Bilal Niazi1, Bill Quach1, Kurt Fisher2
1Department of Gastroenterology and Hepatology, College of Medicine, University of Nebraska Medical Center, Omaha, NE.
选择性雄激素受体调节剂 (SARMs) 可以导致肝损伤. 这一案例突显了RAD-140的长期胆固醇,成功地用皮质类固醇治疗.
科学领域:
- 药理学 药理学 是一个学科.
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
背景情况:
- 选择性雄激素受体调节剂 (SARMs) 是效能增强的化合物,模仿合成安卓激素.
- 虽然SARM并未获得FDA批准,但在促进肌肉生长的补充剂中很普遍.
- 它们的使用与胆固醇性肝损伤有关,类似于类固醇.
更多相关视频
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
COPD: Management Using Bronchodilators and Corticosteroids
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Rheumatic Heart Disease III: Medical Management
